ReviewBritish journal of pharmacology2018
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.
Nathan A Berger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
127 papers cite itlatest 60 shown
this paperpooled itcites it